Vipragen Biosciences Private Limited - Company Profile

It is a pharma private limited company based in Mysore, Karnataka, India, established in 2012.

2012 Mysore, Karnataka, India Active

Last Updated: January 11, 2026

About Vipragen Biosciences Private Limited

Vipragen Biosciences Private Limited, a active private limited company, was established on 11 May 2012 in Mysore, Karnataka, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100KA2012PTC063955. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹8.09 Cr.

It upholds a compliant status. Employing 75 professional, Its leadership includes Umesh Devurkar (Director), Pallavur Viswanathan Harikrishnan (Nominee Director), Siddamadappa Chandrashekaran (Managing Director). Past directors included Umesh Devurkar, Sheshagiri, Siddamadappa Chandrashekaran. It holds ₹5.52 Cr open charges and ₹6.35 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 67B, Hootagalli Industrial Area,, Mysore, Karnataka, 570018.

Company Details

CIN/LLPIN
U73100KA2012PTC063955
Registration Number
063955
Incorporation Date
11 May 2012
Authorized Capital
₹10.00 Cr
Paid-Up Capital
₹8.09 Cr
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 10.00 Cr as on 11-01-2026
Paid Up Capital ₹ 8.09 Cr as on 11-01-2026
Company Age 13 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 5.52 Cr as on 11-01-2026
Satisfied Charges ₹ 6.35 Cr as on 11-01-2026
Revenue Growth **** 1.77% (FY 2023)
Profit Growth **** -796.89% (FY 2023)
Ebitda **** -60.36% (FY 2023)
Net Worth -11.57% (FY 2023)
Total Assets **** 11.26% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Vipragen Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Vipragen Biosciences Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Umesh Devurkar	Director	17 Sep 2012	Current
Pallavur Viswanathan Harikrishnan	Nominee Director	03 Oct 2023	Current
Siddamadappa Chandrashekaran	Managing Director	05 Oct 2015	Current
Yashas	Director	10 Feb 2021	Current
Kannasandra Pushpalatha	Director	01 Jul 2014	Current
Patlapati Harsha Samaraditya	Additional Director	03 Nov 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	09 Sep 2013	Past
Pramod Abcsdd	Director	29 May 2014	Past
Pramod Abcsdd	Director	25 Nov 2021	Past
Pramod Abcsdd	Additional Director	30 Nov 2021	Past
Pramod Abcsdd	Additional Director	31 Dec 2014	Past
Pramod Abcsdd	Additional Director	26 May 2014	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vipragen Biosciences.

Vipragen Biosciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.77% increase. The company also saw a substantial fall in profitability, with a 796.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.57%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

1.77%

*******

Revenue from Operations

*******

1.05%

*******

Total Assets

*******

11.26%

*******

Profit or Loss

*******

-796.89%

*******

Net Worth

*******

-11.57%

*******

EBITDA

*******

-60.36%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vipragen Biosciences?

In 2023, Vipragen Biosciences had a promoter holding of 37.95% and a public holding of 62.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹55,209,558.00

Satisfied Charges

₹63,500,000.00

Charges Breakdown by Lending Institutions

Hdfc Bank Limited : 4.61 Cr
Others : 0.91 Cr

Latest Charge Details

Date	Lender	Amount	Status
18 Sep 2025	Hdfc Bank Limited	₹1.21 M	Open
28 Dec 2023	Hdfc Bank Limited	₹4.49 Cr	Open
31 May 2022	Others	₹9.10 M	Open
19 Jan 2016	State Bank Of Mysore	₹2.70 Cr	Satisfied
27 Sep 2013	State Bank Of India	₹3.65 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Vipragen Biosciences?

Vipragen Biosciences has a workforce of 75 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Vipragen Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vipragen Biosciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vipragen Biosciences

Recent Activity within the Organization

Director Appointment

The activity Patlapati Harsha Samaraditya was appointed as a Additional Director was appointed as a Additional Director on 03 Nov 2025 & has been associated with this company since 3 months 15 days . was completed.
03 Nov 2025
Annual General Meeting

Vipragen Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Charges

The activity A charge with Hdfc Bank Limited amounted to Rs. 0.12 Cr with Charge ID 101192726 was registered on 18 Sep 2025. was completed.
18 Sep 2025
Charges

Progress on A charge with Hdfc Bank Limited of Rs. 4.49 Cr registered on 28 Dec 2023 with Charge ID 100914735 was modified on 30 Jun 2025. was documented.
30 Jun 2025
Balance Sheet

The activity Vipragen Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.
31 Mar 2025
Charges

The activity A charge registered on 19 Jan 2016 via Charge ID 10627000 with State Bank Of Mysore was fully satisfied on 15 Mar 2024. was completed.
15 Mar 2024

Explore recent activity and updates - View Recent Activity